Canadian firm battles GSK
This article was originally published in The Tan Sheet
Executive Summary
Canadian online drug supplier sends Feb. 4 1letter encouraging 100,000 U.S. customers to avoid purchasing GSK's OTC products, such as Aquafresh, Nicorette, Tums, "in light of their anti-U.S. consumer policy." According to The Canadian Drug Store, Glaxo has stopped shipping Rx products to the retailer because it then sells drugs to U.S buyers at lower prices. Letter urges consumers to contact Congressmen and protest high drug prices in U.S. GSK says decision to cease shipments to Canadian firm is due to potential safety issues related to shipping drugs across the border. New York State Wide Senior Action Council called for similar boycott of GSK's products in early January...
You may also be interested in...
GSK OTC Boycott Urged In Multi-State “Tums Down” Campaign
Senior advocacy groups in more than 10 states across the country are urging consumers to boycott GlaxoSmithKline's OTC drug products through press events and postcards, e-mails and telephone calls to GSK and congressional leaders
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.